Publications

5891 Results

ARID1A mutations induce an EGFR-like gene expression signature and confer intrinsic and acquired resistance to cetuximab treatment in first line metastatic CRC

Authors
R Johnson;X Qu;J Thomas;Y Kschonsak;L Huw;F-S Ou;E Sokol;N Ihuegbu;O Zill;O Kabbarah;A Daemen;R Bourgon;A Venook;F Innocenti;H-J Lenz;F de Sousa e Melo;C Bais
Journal / Conference
Cancer Research 2020;80(16 Suppl):Abstract LB-063. Proceedings of the Annual Meeting of the American Association for Cancer Research (AACR), 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA)
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer [Seminars Article; Review]

Authors
L Ballas;P Singh;SP Lerner
Journal / Conference
Urologic Oncology Nov 2;S1078-1439(20)30478-6.
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID33153882
Study Number(s)
S1806

Transdisciplinary research outcomes based on the Transdisciplinary Research on Energetics and Cancer (TREC) Initiative experience

Authors
Hohl SD;Knerr S;Neuhouser M;Beresford SAA;Unger JM;Fishman P;Thompson B
Journal / Conference
Research Evaluation. 2021 Jan:30:39-50. doi: 10.1093/reseval/rvaa026. Epub 2020 Dec 25.
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
35250193
PMC
PMC8896575

Association of the Coronavirus Disease-2019 (COVID-19) Outbreak with Patient Willingness to Enroll in Cancer Clinical Trials

Authors
Fleury ME;Farner AM;Unger JM
Journal / Conference
JAMA Oncol. 2020 Nov 12:3205748
Year
2020
Research Committee(s)
Cancer Care Delivery

Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices

Authors
Williams GR;Du Y;Bell-Brown A;Bolt K;Unger JM.
Journal / Conference
Oncologist. 2020 Dec;25(12):1032-1038
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
32820842
PMC
7938409

Feasibility and Validity of Asking Patients to Define Individual Levels of Meaningful Change on Patient-Reported Outcomes

Authors
Jones SMW;Du Y;Bell-Brown A;Bolt K;Unger JM.
Journal / Conference
J Patient Cent Res Rev. 2020 Jul 27;7(3):239-248
Year
2020
Research Committee(s)
Symptom Management and Survivorship
PMID
32760755
PMC
7398625

Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence

Authors
Tran G;Harker M;Chiswell K;Unger JM;Fleury ME;Hirsch B;Miller K;d’Almada P;Tibbs S;Zafar SY.
Journal / Conference
JCO Clin Cancer Inform. 2020 Jan;4:35-49
Year
2020
Research Committee(s)
Cancer Care Delivery

Key Design and Analysis Principles for Quality of Life and Patient Reported Outcomes in Clinical Trials

Authors
J Unger;R Vaidya;J Gore
Journal / Conference
Urologic Oncology May;37(5):324-330; Mar 21 [Epub ahead of print]
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID29572075
PMC
PMC6148417
Study Number(s)
S1802, S9916

From the other side:The patient perspective on cancer clinical trials [Review]

Authors
R Bangs;A Crispino
Journal / Conference
Urologic Oncology: Seminars and Original Investigations May;37(5):331-335; Feb 7 [Epub ahead of print]
Year
2019
Research Committee(s)
Genitourinary
PMID
PMID29428573
Study Number(s)
S1314

Mechanisms and Funding Opportunities in Genitourinary Cancer Clinical Research [Review]

Authors
C Ryan
Journal / Conference
Urologic Oncology: Seminars and Original Investigations, May;37(5):318-323; Jul 31 [Epub ahead of print]
Year
2019
Research Committee(s)
Cancer Control and Genitourinary
PMID
PMID30072304
Study Number(s)
SWOG-8507, SWOG-8949, SWOG-9217